What are the indications for using dalteparin in patients with chronic kidney disease undergoing hemodialysis?

Dalteparin is indicated for preventing clotting in the extracorporeal circuit during hemodialysis in patients with chronic kidney disease, with evidence supporting its efficacy and safety profiles, albeit requiring careful dose monitoring to mitigate bleeding risks.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-03
DOI
https://doi.org/10.5281/zenodo.23921968
Primary Topic
Dialysis and Renal Disease Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

What are the indications for using dalteparin in patients with chronic kidney disease undergoing hemodialysis?

Tripdatabase
Zenodo (CERN European Organization for Nuclear Research)
Dialysis and Renal Disease Management
article

What are the indications for using dalteparin in patients with chronic kidney disease undergoing hemodialysis?

Tripdatabase
article en

Abstract

Dalteparin is indicated for preventing clotting in the extracorporeal circuit during hemodialysis in patients with chronic kidney disease, with evidence supporting its efficacy and safety profiles, albeit requiring careful dose monitoring to mitigate bleeding risks.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 13%
Dialysis and Renal Disease Management
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
What are the indications for using dalteparin in patients with chronic kidney disease undergoing hemodialysis? — Tripdatabase · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS